By 2026 Hormonal Contraceptive Market Burst to Touch $ 26.5 Bn

The Global Hormonal Contraceptive Market Size is poised to reach around USD 26.5 billion by 2026 and will grow at a CAGR of 4.2 % during the forecast period 2019 - 2026

Hormone contraception is a kind of endocrine-active avoidance technique. Different female hormones are used in this technique to avoid ovulation. In combination forms, such as estrogen and progestin, two types of hormonal contraceptive formulations are accessible. The only way to contain progesterone or any one of its synthetic analogs, however, is progesterol. In a combination process, ovulation and thickening of cervical mucus is suppressed and the therapeutic effect is attained, while progestin only decreases ovulation frequency.

Worldwide, women have a large use of global hormonal contraception. The adoption of birth control hormonal contraception is boosted by knowledge of the society when making accurate choices concerning reproductive and sexual health. The increase of hormonal contraception is fuelled by increasing global women's population, urbanization and a growing awareness of hormonal contraception and promoting the promotion of hormonal contraception in NGOs and in public policies. Instead of continuous contraception, implementing temporary and low-cost contraceptive practices is a crucial driving factor in the worldwide hormones industry. During the forecast period the adverse side effects related to the use of hormonal contraceptives are an important obstacle for the world economy.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1482

Focus on family planing and the need to protect against unintentional pregnancies are the main drivers of market growth. Advances with increased efficiency and less side-effect in hormonal contraception are anticipated to further stimulate market growth. In addition, the problems in health of teens, awareness of contemporary techniques of contraception, and the increased use of oral pills as a main technique to avoid unplanned pregnancy, are contributing to the development of markets. However, market growth has a negative effect on accessibility of alternative contraceptive methods, hazards to health from the use of contraceptive products and the absence of social recognition.

The worldwide market was lead by North America in 2018 and its position over the forecast period is anticipated to continue. This can be due to the elevated revenue per capita, a powerful presence of important players in the industry, increased awareness of sexual health and a high amount of unintended pregnancies. Many developing countries, like Germany and the United Kingdom. A number of actions are being taken to educate the public on hormone contraceptive market apps. In future years, this will drive the development of the world hormonal contraceptive industry.

In the forecast period, Asia-Pacific is expected to see the rapidest development. The significant variables complementing regional development include a large fertile population, the introduction of fresh women contraception systems, an increase in investment by market players and powerful economic growth. Countries like China, India and Japan give important market possibilities, owing to population growth, an increase in lifestyle disease prevalence, an increase in infertility, PCOS and public family planning programmes. The Middle East and Africa market are projected to be propelled by an increasing amount of product launches, favourable government’s initiatives and public awareness. For example, the contract to expand access to Implanon was expanded by Merck & Co. and their government sector partners, in May 2017. Under this contract, Implanon NXT (etonogestrel) was to decrease its implant cost over the next six years in 70 poor nations and its next generation medical product.

Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

Explore Our Market Blog@ https://www.acumenresearchandconsulting.com/blogs

Key Players & Strategies

The hormonal contraceptives market consists of major vendors such Allergan; Pfizer; Afaxys, Inc.; Agile Therapeutics; Bayer AG; Merck & Co. Inc.; Teva Pharmaceuticals Industries Ltd.; and Apothecus Pharmaceutical Corporation. Industry has seen a number of inorganic growth projects and technological progress in system design to strengthen its sector leadership.

TEVA, for example, launched Minastrin 24 Fe-ethinyl estradiol and norethindron acetate and ferrous fumarate tablets, which have been used as an oral contraceptive in the United Nations in March 2018.

In 2017, to avoid pregnancy, Bayer Inc. launched Kyleena, a fresh IUS. It is anticipated that Kyleena will be launched to address the long term contraception requirement for women up to five years.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Hormonal Contraceptives
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Hormonal Contraceptives Market By Product Type
1.2.2.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.2.2. Global Hormonal Contraceptives Market Revenue Share By Product Type in 2017
1.2.2.3. Oral Contraceptive Pills
1.2.2.4. Vaginal Rings
1.2.2.5. Emergency Contraceptive Pills
1.2.2.6. Transdermal Patches
1.2.2.7. Injectable Birth Control
1.2.3. Hormonal Contraceptives Market By Hormone
1.2.3.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By Hormone (2015-2026)
1.2.3.2. Combined Hormonal Contraceptive
1.2.3.3. Progestin-only Contraceptive
1.2.4. Hormonal Contraceptives Market By End User
1.2.4.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison By End User (2015-2026)
1.2.4.2. Hospitals
1.2.4.3. Clinics
1.2.4.4. Household
1.2.5. Hormonal Contraceptives Market by Geography
1.2.5.1. Global Hormonal Contraceptives Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Hormonal Contraceptives Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Hormonal Contraceptives Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Hormonal Contraceptives Major Manufacturers in 2017
3.3. R&D Status and Technology Product Type of Global Hormonal Contraceptives Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Hormonal Contraceptives Major Manufacturers in 2017

CHAPTER 4. HORMONAL CONTRACEPTIVES MARKET BY PRODUCT TYPE

4.1. Global Hormonal Contraceptives Revenue By Product Type
4.2. Oral Contraceptive Pills
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Vaginal Rings
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Emergency Contraceptive Pills
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Transdermal Patches
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Injectable Birth Control
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. HORMONAL CONTRACEPTIVES MARKET BY HORMONE

5.1. Global Hormonal Contraceptives Revenue By Hormone
5.2. Combined Hormonal Contraceptive
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Progestin-only Contraceptive
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. HORMONAL CONTRACEPTIVES MARKET BY END USER

6.1. Global Hormonal Contraceptives Revenue By End User
6.2. Hospitals
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinics
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Household
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

7.1. North America Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Hormonal Contraceptives Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

8.1. Europe Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

9.1. Asia-Pacific Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

10.1. Latin America Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

11.1. Middle East Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA HORMONAL CONTRACEPTIVES MARKET BY COUNTRY

12.1. Africa Hormonal Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa Hormonal Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Product Type, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Hormone, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End User, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Allergan
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Pfizer
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Afaxys, Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Agile Therapeutics
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Bayer AG
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Merck & Co. Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Teva Pharmaceuticals Industries Ltd.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Apothecus Pharmaceutical Corporation
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Others
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1482

The report is readily available and can be dispatched immediately after payment confirmation.